Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
Address
100 SPY COURT
MARKHAM, A6 L3R 5H6
Founded
2007
Number of Employees
16
Website
http://www.edesabiotech.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)